Abbott Laboratories (LON:0Q15)

Market Cap	171.28B
Revenue (ttm)	32.77B
Net Income (ttm)	10.41B
Shares Out	n/a
EPS (ttm)	5.96
PE Ratio	16.45
Forward PE	25.32
Dividend	1.77 (1.32%)
Ex-Dividend Date	Apr 15, 2025

Volume	2,312
Average Volume	3,430
Open	134.67
Previous Close	134.57
Day's Range	133.26 - 135.33
52-Week Range	98.50 - 141.41
Beta	0.66
RSI	49.39
Earnings Date	Jul 16, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD